BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

436 related articles for article (PubMed ID: 6140096)

  • 1. Dexamethasone suppression test in diagnosis of depressive illness.
    Hayes PE; Ettigi P
    Clin Pharm; 1983; 2(6):538-45. PubMed ID: 6140096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Influence of depressive history on biological parameters in major depression].
    Van Wijnendaele R; Hubain P; Dramaix M; Mendlewicz J; Linkowski P
    Encephale; 2002; 28(1):51-8. PubMed ID: 11963343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The dexamethasone suppression test and response to somatic treatment: a review.
    Gitlin MJ; Gerner RH
    J Clin Psychiatry; 1986 Jan; 47(1):16-21. PubMed ID: 3510195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The dexamethasone suppression test in prepubertal depressed children.
    Weller EB; Weller RA; Fristad MA; Preskorn SH; Teare M
    J Clin Psychiatry; 1985 Dec; 46(12):511-3. PubMed ID: 4066616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lithium augmentation increases post-dexamethasone cortisol in the dexamethasone suppression test in unipolar major depression.
    Bschor T; Baethge C; Adli M; Eichmann U; Ising M; Uhr M; Müller-Oerlinghausen B; Bauer M
    Depress Anxiety; 2003; 17(1):43-8. PubMed ID: 12577277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The dexamethasone test and the choice of treatment and drug in depression].
    Fornaro P; Lippi P; Allegretti M
    Minerva Psichiatr; 1992; 33(3):177-83. PubMed ID: 1474881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [In unipolar depression does the response to the dexamethasone suppression test predict a symptomatic recurrence after clinical cure?].
    Charles G; Schittecatte M; Maes JM; Rush AJ; Wilmotte J
    Acta Psychiatr Belg; 1986; 86(3):249-56. PubMed ID: 3751648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dexamethasone suppression tests in psychiatry: is there a place for an integrated hypothesis?
    Abou-Saleh MT
    Psychiatr Dev; 1985; 3(3):275-306. PubMed ID: 2999762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Defining the boundaries of atypical depression: evidence from the HPA axis supports course of illness distinctions.
    Stewart JW; Quitkin FM; McGrath PJ; Klein DF
    J Affect Disord; 2005 Jun; 86(2-3):161-7. PubMed ID: 15935235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Objectifying psychiatric diagnosis and treatment with the dexamethasone suppression test.
    Pollock DC; Sheehan ME
    J Fam Pract; 1982 Oct; 15(4):641-5. PubMed ID: 6288832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of clinical course by dexamethasone suppression test (DST) response in depressed patients - physiological and clinical construct validity of the DST.
    Holsboer F
    Pharmacopsychiatria; 1983 Nov; 16(6):186-91. PubMed ID: 6665028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The dexamethasone suppression test in depression. Critical review].
    Bailly D; Goudemand M; Parquet PJ
    Encephale; 1984; 10(4):155-69. PubMed ID: 6389093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hypothalamic-pituitary-adrenal and hypothalamic-pituitary-thyroid axis findings in depressive disorder].
    Sarandöl A; Taneli B; Sivrioğlu Y
    Turk Psikiyatri Derg; 2003; 14(2):116-24. PubMed ID: 12844278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The dex/CRH test--is it better than the DST?
    Watson S; Gallagher P; Smith MS; Ferrier IN; Young AH
    Psychoneuroendocrinology; 2006 Aug; 31(7):889-94. PubMed ID: 16701957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Melatonin, cortisol and ACTH in patients with major depressive disorder and healthy humans with special reference to the outcome of the dexamethasone suppression test.
    Beck-Friis J; Ljunggren JG; Thorén M; von Rosen D; Kjellman BF; Wetterberg L
    Psychoneuroendocrinology; 1985; 10(2):173-86. PubMed ID: 2994141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in serial dexamethasone suppression tests among unipolar depressive receiving electroconvulsive treatment.
    Albala AA; Greden JF; Tarika J; Carroll BJ
    Biol Psychiatry; 1981 Jun; 16(6):551-60. PubMed ID: 7260217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychoneuroendocrinology of depression.
    Brown GM
    Psychiatr J Univ Ott; 1989 Jun; 14(2):344-8; discussion 349-51. PubMed ID: 2503840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma corticosterone, dexamethasone (DEX) suppression and DEX/CRH tests in a rat model of genetic vulnerability to depression.
    Steimer T; Python A; Schulz PE; Aubry JM
    Psychoneuroendocrinology; 2007 Jun; 32(5):575-9. PubMed ID: 17512120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pituitary-adrenal disinhibition as the independent variable in the assessment of behavioral symptoms.
    Reus VI
    Biol Psychiatry; 1982 Mar; 17(3):317-26. PubMed ID: 7082699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The dexamethasone suppression test in depressed patients: clinical and biochemical aspects.
    Holsboer F
    J Steroid Biochem; 1983 Jul; 19(1A):251-7. PubMed ID: 6887861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.